Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+209.8%
5Y CAGR+111.1%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+209.8%/yr
vs -8.1%/yr prior
5Y CAGR
+111.1%/yr
Recent acceleration
Acceleration
+217.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
42x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.89M | +16.8% |
| 2024 | $21.31M | +246.7% |
| 2023 | $6.15M | +634.4% |
| 2022 | $837000.00 | +654.1% |
| 2021 | $111000.00 | -81.3% |
| 2020 | $593000.00 | -72.3% |
| 2019 | $2.14M | +82.8% |
| 2018 | $1.17M | +143.2% |
| 2017 | $482000.00 | +97.5% |
| 2016 | $244000.00 | - |